Conduct synthesis and acquire batches of compounds for subsequent biological in vitro and in vivo testing
Ended Awarded Last action
- Contract number
- 75N93024F00001
- Awardee
-
Starks Associates Inc. UEI DAY5FJMYL4L8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,264,071
Award facts
- Contract value 100% obligated
- $1,264,071.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Buffalo, NY 14213, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the Department of Health and Human Services' National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to support preclinical services for HIV therapeutics. The prime contractor, Starks Associates Inc., a for-profit subchapter S corporation, will conduct synthesis and acquisition of compounds for subsequent biological in vitro and in vivo testing. The work is being performed under a delivery order against an indefinite-delivery/indefinite-quantity (IDIQ) contract with a potential value of $107 million over seven years, which covers preclinical development support for candidate HIV treatments and related infectious disease products. The current delivery order has a potential value of $1,264,071.00 and will be priced on a cost-plus-fixed-fee basis. The work will take place at Starks Associates' facilities in Buffalo, New York. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N93024F00001?
75N93024F00001 was awarded to Starks Associates Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 1, 2024.
How much is contract 75N93024F00001 worth?
The government has obligated $1,264,071 on 75N93024F00001.
Is contract 75N93024F00001 an order under another contract?
Yes. 75N93024F00001 is a delivery order under 75N93021D00005, an indefinite delivery contract, on Preclinical Services for HIV Therapeutics.
Was contract 75N93024F00001 competed?
The extent of competition for 75N93024F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award